Medicenna Therapeutics Corp(TSE:MDNA)
CA$0.39-0.02 (-6.02%)
TSE:MDNA
Medicenna Therapeutics Corp financials statements
CA$0.39
At close:-0.02 (-6.02%)
Want to see TSE:MDNA full AI Analyst Report?
Medicenna Therapeutics Corp (MDNA) Income Statement
223 Followers
Medicenna Therapeutics Corp Income Statement
Last quarter (Q1 2027), Medicenna Therapeutics Corp's total revenue was C$0.00. In Q1, Medicenna Therapeutics Corp's net income was C$-5.08M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | |
| C$ -77.00K | C$ -55.00K | C$ -5.00K | C$ -5.00K | C$ -38.00K | |
| C$ 23.63M | C$ 21.58M | C$ 19.66M | C$ 16.30M | C$ 22.47M | |
| Depreciation and Amortization | C$ 72.00K | C$ 53.00K | C$ 4.00K | C$ 4.00K | C$ 38.00K |
| C$ -23.64M | C$ -12.98M | C$ -18.67M | C$ -16.30M | C$ -22.54M | |
| C$ -23.71M | C$ -21.63M | C$ -19.66M | C$ -21.64M | C$ -22.30M | |
| C$ 4.01M | C$ 8.60M | C$ -5.80M | C$ 7.00M | C$ 1.65M | |
| C$ -19.70M | C$ -13.03M | C$ -25.47M | C$ -10.05M | C$ -22.58M | |
| C$ -18.41M | C$ -11.80M | C$ -25.47M | C$ 1.55M | C$ -22.65M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.22 | C$ -0.15 | C$ -0.37 | C$ 0.02 | C$ -0.42 |
| Diluted EPS | C$ -0.22 | C$ -0.15 | C$ -0.37 | C$ 0.02 | C$ -0.42 |
| Weighted Average Shares Outstanding | 83.19M | 76.67M | 69.64M | 64.74M | 54.29M |
| Weighted Average Shares Outstanding (Diluted) | 83.19M | 76.67M | 69.64M | 64.74M | 54.29M |
Currency in CAD
